SlideShare une entreprise Scribd logo
1  sur  57
Télécharger pour lire hors ligne
Multiparticulate Drug Delivery Systems
Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D
Professor of Pharmaceutics
KLE University College of Pharmacy,
Belgaum-590 010 Karnataka, India.
1
25Feb.2011AllianceInstitute,Hyderabad
CONTENT
 Multiparticulate Drug Delivery Systems.
 Pellets.
 Pelletization Techniques .
 Extrusion Spheronization .
 Melt Extrusion.
 Mini Tablets.
2
25Feb.2011AllianceInstitute,Hyderabad
Multiparticulate Drug Delivery Systems
 Pharmaceutical invention and research are
increasingly focusing on delivery systems
which enhance desirable therapeutic
objectives while minimising side effects.
 Recent trends indicate that
multiparticulate drug delivery systems are
especially suitable for achieving controlled
or delayed release oral formulations with low
risk of dose dumping, flexibility of blending
to attain different release patterns as well
as reproducible and short gastric residence
time.
3
25Feb.2011AllianceInstitute,Hyderabad
 The release of drug from microparticles
depends on a variety of factors including
the carrier used to form the
multiparticles and the amount of drug
contained in them.
 Consequently, multiparticulate drug
delivery systems provide tremendous
opportunities for designing new controlled
and delayed release oral formulations, thus
extending the frontier of future
pharmaceutical development.
4
Multiparticulate Drug Delivery Systems
25Feb.2011AllianceInstitute,Hyderabad
Multiparticulate Drug Delivery Systems
 Multi-particulate drug delivery systems are
mainly oral dosage forms consisting of a
multiplicity of small discrete units, each
exhibiting some desired characteristics.
 In these systems, the dosage of the drug
substances is divided on a plurality of
subunit, typically consisting of thousands of
spherical particles with diameter of 0.05-
2.00mm.
5
25Feb.2011AllianceInstitute,Hyderabad
 Thus multiparticulate dosage forms are
pharmaceutical formulations in which the
active substance is present as a number of
small independent subunits.
 To deliver the recommended total dose,
these subunits are filled into a sachet and
encapsulated or compressed into a tablet.
6
Multiparticulate Drug Delivery Systems
25Feb.2011AllianceInstitute,Hyderabad
 Multiparticulates are discrete particles that
make up a multiple unit system. They provide
many advantages over single-unit systems
because of their small size.
 Multiparticulates are less dependent on
gastric empyting, resulting in less inter and
intra-subject variability in gastrointestinal
transit time. They are also better distributed
and less likely to cause local Irritation.
Multiparticulate Drug Delivery Systems
7
25Feb.2011AllianceInstitute,Hyderabad
 Recently much emphasis is being laid on the
development of multiparticulate dosage
forms in preference to single unit systems
because of their potential benefits such as
increased bioavailability, reduced risk of
systemic toxicity, reduced risk of local
irritation and predictable gastric emptying.
Multiparticulate Drug Delivery Systems
8
25Feb.2011AllianceInstitute,Hyderabad
Multiparticulate Drug Delivery Systems
 There are many reasons for formulating a
drug as a multiparticulate system for
example, to facilitate disintegration in the
stomach, or to provide a convenient, fast
disintegrating tablet that dissolves in water
before swallowing which can aid compliance
in older patients and children.
 Multiparticulate systems show better
reproducible pharmacokinetic behavior than
conventional (monolithic) formulations. 9
25Feb.2011AllianceInstitute,Hyderabad
 After disintegration which occurs within a few
minutes often even within seconds, the
individual subunit particles pass rapidly
through the GI tract.
 If these subunits have diameters of less than
2mm, they are able to leave the stomach
continuously, even if the pylorus is closed.
 These results in lower intra and inter individual
variability in plasma levels and bioavailability. 10
Multiparticulate Drug Delivery Systems
25Feb.2011AllianceInstitute,Hyderabad
MECHANISM OF DRUG RELEASE FROM MULTI-
PARTICULATES
 The mechanism of drug release from
multiparticulates can be occur in the following
ways:-
 Diffusion
 Erosion
 Osmosis
11
25Feb.2011AllianceInstitute,Hyderabad
MECHANISM OF DRUG RELEASE FROM MULTI-
PARTICULATES
 Diffusion :-
On contact with aqueous fluids in the gastrointestinal tract
(GIT), water diffuses into the interior of the particle. Drug
dissolution occurs and the drug solutions diffuse across the
release coat to the exterior.
 Erosion :-
Some coatings can be designed to erode gradually with time,
thereby releasing the drug contained within the particle.
 Osmosis :-
In allowing water to enter under the right circumstances, an
osmotic pressure can be built up within the interior of the
particle. The drug is forced out of the particle into the
exterior through the coating.
12
25Feb.2011AllianceInstitute,Hyderabad
PELLETS
o WHAT IS PELLETS:-
o Traditionally, the word "pellet" has been used to
describe the variety of systematically produced,
geometrically defined agglomerates obtained from
diverse starting materials utilizing different
processing conditions.
o These products may be fertilizers, Animal feeds,
Iron Ores or Pharmaceutical Dosage forms.
o Pellets are small spherical free flowing units with
improved flow properties and flexibility in
formulation development and manufacture. 13
25Feb.2011AllianceInstitute,Hyderabad
PELLETS
 Their size and shape allow their administration
as injections and also for oral drug delivery.
 Pellets range in size, typically, between 0.5 – 1.5
mm, though other sizes could be prepared.
 Pellets are for pharmaceutical purposes and are
produced primarily for the purpose of oral
controlled-release dosage forms having gastro
resistant or sustained-release properties or the
capability of site-specific drug delivery.
14
25Feb.2011AllianceInstitute,Hyderabad
PELLETS
 For such purposes, coated pellets are administered
in the form of hard gelatin capsules or
disintegrating tablets that quickly liberate their
contents of pellets in the stomach.
 As drug-delivery systems become more
sophisticated, the role of pellets in the design and
development of dosage forms is increasing.
 Formulation of drugs in multiple-unit dosage forms,
such as coated pellets filled in capsules or
compressed into tablets, offers flexibility as to
target-release properties. 15
25Feb.2011AllianceInstitute,Hyderabad
WHY PELLETS?
 Excellent Stability.
 Dust free Round pellets.
 Good flow behavior.
 Easy to dose.
 Compact structure.
 Very Low hygroscopicity.
 High bulk density.
 Dense, uniform surface.
PELLETIZATION
16
25Feb.2011AllianceInstitute,Hyderabad
 Narrow grain size distribution.
 Low abrasion.
 High active ingredient content possible.
 Optimum starting shape for subsequent
coating.
 Controlled-release applications.
 Drug absorption.
 The risks of the local damage to the GI-
tract mucosal.
WHY PELLETS?
17
25Feb.2011AllianceInstitute,Hyderabad
ADVANTAGES OF PELLETS
 They can be divided in to desired dosage strength
without process or formulation changes.
 When pellets containing the active ingredient are in
the form of suspension, capsules, or disintegrating
tablets, they offer significant therapeutic
advantages over single unit dosage forms.
 They can also be blended to deliver incompatible
bioactive agents.
 They can also be used to provide different release
profile at the same or different sites in the
gastrointestinal tract.
18
25Feb.2011AllianceInstitute,Hyderabad
ADVANTAGES OF PELLETS
 Pellets offer high degree of flexibility in the
design and development of oral dosage form like
suspension, sachet, tablet and capsule.
 Pellets disperse freely in GI tract, maximize drug
absorption, and minimize local irritation of the
mucosa by certain irritant drugs.
 Improved flow characteristics: Spheres have
excellent flow properties which can be used in
automated processes or in processes where exact
dosing is required, e.g. tabletting, moulding
operations, capsule filling, and packaging. 19
25Feb.2011AllianceInstitute,Hyderabad
Disadvantages of Pellets
 Dosing by volume rather than number and
splitting into single dose units as required.
 Involves capsule filling which can increase
the costs or tabletting which destroy film
coatings on the pellets.
 The size of pellets varies from formulation
to formulation but usually lies between 1 to
2mm. 20
25Feb.2011AllianceInstitute,Hyderabad
PELLETIZATION
DEFINITION OF PELLETIZATION
 Pelletization is an agglomeration process,
that converts fine powder blend of drug(s)
and Excipients into small, free flowing,
spherical units, referred to as pellets.
21
25Feb.2011AllianceInstitute,Hyderabad
PELLETIZATION
 Pelletization is referred to as a size
enlargement process and if the final
agglomerates are spherical with a size of
0.5-2.0 mm and low intra-agglomerate
porosity (about 10%), they are called
pellets.
22
25Feb.2011AllianceInstitute,Hyderabad
PELLETIZATION TECHNIQUES
 Powder layering Solution/Suspension
layering.
 Extrusion–Spheronization.
 Spherical agglomeration or balling Spray
congealing/ drying.
 Cryopelletization and,
 Melt Spheronization.
23
25Feb.2011AllianceInstitute,Hyderabad
PELLETIZATION TECHNIQUES
POWDER LAYERING
 Powder layering involves the deposition of
successive layers of dry powder of drug or
excipients or both on preformed nuclei or
cores with the help of a binding liquid.
 Powder layering involves the simultaneous
application of the binding liquid and dry
powder.
24
25Feb.2011AllianceInstitute,Hyderabad
POWDER LAYERING
 The first equipment used to manufacture
pellets on a commercial scale was the
conventional coating pan, but it has
significant limitations as pelletization
equipment.
 The degree of mixing is very poor, and
the drying process is not efficient
25
PELLETIZATION TECHNIQUES
25Feb.2011AllianceInstitute,Hyderabad
POWDER LAYERING
Principle of Powder layering process 26
25Feb.2011AllianceInstitute,Hyderabad
POWDER LAYERING
 Throughout the process, it is extremely important to
deliver the powder accurately at a predetermined
rate and in a manner that maintains equilibrium
between the binder liquid application rate and the
powder delivery rate.
 If the powder delivery rate is not maintained at
predetermined equilibrium levels, over wetting or
dust generation may occur, and neither the quality
nor the yield of the product can be maximized.
 In an ideal process, no agglomeration occurs, and the
particle population at the end of the process remains
the same as that of the starter seeds or cores, with
the only difference being an increase in the size of
the pellets
27
25Feb.2011AllianceInstitute,Hyderabad
Solution/Suspension layering
 Solution/suspension layering involves the deposition
of successive layers of solutions and/or suspensions
of drug substances and binders on starter seeds,
which may be inert materials or crystals/granules of
the same drug.
 A starting grain or a pellet can be presented as the
starting material. The pellet is built up to the
required grain size by adding the layering substance
one layer at a time. Powder and binders, suspensions
or solutions make suitable layering substances.
28
25Feb.2011AllianceInstitute,Hyderabad
Solution/Suspension layering
 Thick layers can be applied to the starting grains,
which, in the case of layers containing active
ingredients, allow large amounts of active
ingredient to be incorporated.
29
25Feb.2011AllianceInstitute,Hyderabad
Solution/Suspension layering
 An important factor that needs to be considered
when suspensions are used as opposed to solutions
is the particle size of the drug.
 Micronized drug particles tend to provide pellets
that are smooth in appearance, a property that is
extremely desirable during subsequent film
coating, particularly for controlled-release
applications.
30
25Feb.2011AllianceInstitute,Hyderabad
Solution/Suspension layering
 If the particle size of the drug in the suspension
is large, the amount of binder required to
immobilize the particles onto the cores will be
high, and, consequently, pellets of low potency
are produced.
 The morphology of the finished pellets also
tends to be rough and may adversely affect the
coating process and the coated product.
31
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 Compared to single-unit dosage forms, oral
multiparticulate drug-delivery systems (e.g. pellets,
granules) offer biopharmaceutical advantages in
terms of a more even and predictable distribution
and transportation in the gastro-intestinal tract.
 There are different pelletizations and granulation
techniques available to prepare drug loaded
spherical particles or granules.
 Extrusion Spheronization is one of them and
utilized in formulation of beads and pellets. 32
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 Limitations related to bioavailability and site specific
drug delivery can be over come by this technique.
 Today this technology has gained attention because
of its simple and fast processing.
 Extrusion spheronization is widely utilized in
formulation of sustained release, controlled release
delivery system.
 The main objective of the extrusion spheronization is
to produce pellets/spheroids of uniform size with
high drug loading capacity.
33
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 The extrusion-spheronization process is commonly
used in the pharmaceutical industry to make
uniformly sized spheroids.
 It is especially useful for making dense granules
for controlled-release solid dosage oral forms with
a minimum amount of excipients.
 Extrusion/spheronization begins with extrusion
process in which the wet metered mass is placed
into the extruder where it is continuously formed
into cylindrical rods of uniform size and shape. 34
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 Amount of granulating fluid and uniform dispersion
of fluid plays an important role in preparation of
wet mass as optimum plasticity and cohesiveness
directly affect the final production of pellets.
 Once the extrudates are prepared, they are then
taken to spheroniser where it is spheronized or
rotated at higher speed by friction plate that
breaks the rod shaped particles into smaller
particles and round them to form spheres.
35
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 The size of the spheroids mainly depends on
the diameter of circular die that modifies
the diameter of cylindrical rods produced in
extrusion stage.
36
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 The extrusion-spheronization process can be
broken down into the following steps:
1.  Dry mixing of the active ingredients and
excipients to achieve a homogenious powder.
2. Wet massing, with binder added to the dry
mixture
3. Extrusion into a spaghetti-like extrudate.
4. Spheronization to from the extrudate in to
spheroids of uniform size.
5. Drying.
6. Dry sizing, or sifting (optional) to achieve the
desired size distribution
7. Coating (optional). 37
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 The extrusion-spheronization process can be
broken down.
38
25Feb.2011AllianceInstitute,Hyderabad
Extrusion Spheronization
 Product features
• Dust free
• High spherocity
• Free flowing
• Compact structure
• Low hygroscopicity
• High bulk density
• Low abrasion
• Narrow particle size distribution
• Smooth surface 39
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
 Melt extrusion is one of the most widely applied
processing technologies in the plastic, rubber and
food industry. Today this technology has found its
place in the array of pharmaceutical manufacturing
operations.
 Melt extrusion process are currently applied in the
pharmaceutical field for the manufacture of a
variety of dosage forms and formulations such as
granules, pellets, tablets, suppositories, implants,
stents, transdermal systems and ophthalmic inserts.
40
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
Advantages:
 Neither solvent nor water used in this
process.
 Fewer processing steps needed thus time
consuming drying steps eliminated.
 There are no requirements on the
compressibility of active ingredients and
the entire procedure simple, continuous
and efficient. 41
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
Advantages:
 Uniform dispersion of fine particle
occurs.
 
 Good stability at varying pH and moisture
levels.
 
 Safe application in humans due to their
non-swellable and water insoluble nature
42
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
Disadvantages:
  Requires high energy input.
 
 The melt technique is that the process
cannot be applied to heat-sensitive materials
owing to the elevated temperatures involved.
 
 Lower-melting-point binder risks situations
where melting or softening of the binder
occurs during handling and storage of the
agglomerates 43
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
Applications in the pharmaceutical industry:
 In pharmaceutical industry the melt extrusion has
been used for various purposes, such as
 1. Improving the dissolution rate and bioavailability
of the drug by forming a solid  dispersion or solid
solution.
 
 2. Controlling or modifying the release of the drug.
 3.    Masking the bitter taste of an active drug
44
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
 Melt extrusion technology has proven to be a suitable
method for the production of controlled release
reservoir systems consisting of polyethylene vinyl
acetate (PVA) co-polymers.
 Based on this technology, two controlled release
systems Implanon® and Nuvaring® have been
developed.
 A melt extrusion process for manufacturing matrix
drug delivery system was reported by Sprockel and co-
workers. In 1994 Follonier and co-workers investigated
hot-melt extrusion technology to produce sustained-
release pellets.
45
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
Process and Equipment:
 Hot-melt extrusion equipment consists of an
extruder, auxiliary equipment for the extruder, down
stream processing equipment, and other monitoring
tools used for performance and product quality
evaluation.
 The extruder is typically composed of a feeding
hopper, barrels, single or twin screws, and the die and
screw– driving unit
46
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
Figure: Micro-18 Twin screw co-rotating Leistritz extruder
47
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
 The auxiliary equipment for the extruder mainly
consists of a heating/cooling device for the barrels,
a conveyer belt to cool down the product and a
solvent delivery pump.
 The monitoring devices on the equipment include
temperature gauges, a screw-speed controller, an
extrusion torque monitor and pressure gauges.
 The monitoring devices on the equipment include
temperature gauges, a screw-speed controller, an
extrusion torque monitor and pressure gauges. 48
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
 The theoretical approach to understanding the melt
extrusion process is therefore, generally presented
by dividing the process of flow into four sections:
1) Feeding of the extruder.
2) Conveying of mass (mixing and reduction of
particle size).
3) Flow through the die.
4) Exit from the die and down-stream processing. 49
25Feb.2011AllianceInstitute,Hyderabad
MELT EXTRUSION
Figure 2. Heating barrels and co-rotating screws for hot-melt extruder
50
25Feb.2011AllianceInstitute,Hyderabad
MINI TABLETS
 It is well known that solid oral dosage form,
particularly tablets, are the most acceptable
form of delivering medication.
 However, some new variations are beginning to
emerge such as mini-tabs, which offer
formulation flexibility.
51
25Feb.2011AllianceInstitute,Hyderabad
 Mini-tabs are small tablets with a diameter
typically equal to or less than 3 mm that
are typically filled into a capsule, or
occasionally, further compressed into
larger tablets.
 It is possible to incorporate many different
mini-tablets, each one formulated
individually and programmed to release drug
at different sites within the
gastrointestinal track, into one capsule. 52
MINI TABLETS
25Feb.2011AllianceInstitute,Hyderabad
MINI TABLETS
Fig: Minitab
53
25Feb.2011AllianceInstitute,Hyderabad
MINI TABLETS
Fig. Mini-tablets delivered as a tablet (a) or a capsule (b).
54
25Feb.2011AllianceInstitute,Hyderabad
MINI TABLETS
 These combinations may include immediate release,
delayed release, and/or controlled release mini-tabs.
 It is also possible to incorporate mini-tabs of
different drugs to treat concurrent diseases or
combinations of drugs to improve overall therapeutic
outcome, while delivering distinct release rates of
each according to disease requirements.
 Mini-tabs could also offer a solution to the current
issue in the pharmaceutical industry representing a
lack of dosage forms which are suitable for
pediatrics. 55
25Feb.2011AllianceInstitute,Hyderabad
MINI TABLETS
 Additional benefits of mini-tabs include excellent size
uniformity, regular shape and a smooth surface,
thereby offering an excellent substrate for coating
with modified release polymeric systems.
 They can be produced via direct compression and can
be manufactured using conventional tableting machines
with only minor equipment modifications.
 For example, in order to increase production speeds,
multiple-tip tooling has been employed routinely.
Furthermore, mini-tabs can be coated using either a
perforated coating pan or a fluid bed apparatus. 56
25Feb.2011AllianceInstitute,Hyderabad
ThankThank
You...You...
57
E-mail: bknanjwade@yahoo.co.in
Cell No:00919742431000
25Feb.2011AllianceInstitute,Hyderabad

Contenu connexe

Tendances

sustained release drug delivery system
sustained release drug delivery systemsustained release drug delivery system
sustained release drug delivery systemprashant mane
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemRahul Shirode
 
Bioadhesive drug delivery system
Bioadhesive drug delivery systemBioadhesive drug delivery system
Bioadhesive drug delivery systemDr. Shreeraj Shah
 
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptx
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptxSUSTAINED RELEASE (SR) & CONTROL RELEASE.pptx
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptxRAHUL PAL
 
oral controlled drug delivery system
oral controlled drug delivery systemoral controlled drug delivery system
oral controlled drug delivery systemBaliram Musale
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery systemJamia Hamdard
 
floating drug delivery system
floating drug delivery systemfloating drug delivery system
floating drug delivery systemfirdous asma
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery systemAnita Duduskar
 
Controlled drug delivery systems
Controlled drug delivery systemsControlled drug delivery systems
Controlled drug delivery systemsTheabhi.in
 
Types of superdisintegrants
Types of superdisintegrantsTypes of superdisintegrants
Types of superdisintegrantsVarshaBarethiya
 
Compression coated tablet techniques by prashik
Compression coated tablet techniques by prashikCompression coated tablet techniques by prashik
Compression coated tablet techniques by prashikprashikvaidya
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemArshad Khan
 
Microsphere & microcapsules
Microsphere & microcapsulesMicrosphere & microcapsules
Microsphere & microcapsulesPravin Chinchole
 
Novel drug delivery system: Niosomes
Novel drug delivery system: NiosomesNovel drug delivery system: Niosomes
Novel drug delivery system: NiosomesSanjay Yadav
 
Dissolution profile comparison
Dissolution profile comparisonDissolution profile comparison
Dissolution profile comparisonMohammad Imran
 
Physics of tablet compression
Physics of tablet compressionPhysics of tablet compression
Physics of tablet compressionMahadev Birajdar
 
NIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATIONNIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATIONMUSTAFIZUR RAHMAN
 
Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]Nagaraju Ravouru
 

Tendances (20)

sustained release drug delivery system
sustained release drug delivery systemsustained release drug delivery system
sustained release drug delivery system
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Formulation and evaluation of microspheres
Formulation and evaluation of microspheresFormulation and evaluation of microspheres
Formulation and evaluation of microspheres
 
Bioadhesive drug delivery system
Bioadhesive drug delivery systemBioadhesive drug delivery system
Bioadhesive drug delivery system
 
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptx
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptxSUSTAINED RELEASE (SR) & CONTROL RELEASE.pptx
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptx
 
oral controlled drug delivery system
oral controlled drug delivery systemoral controlled drug delivery system
oral controlled drug delivery system
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
 
floating drug delivery system
floating drug delivery systemfloating drug delivery system
floating drug delivery system
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
 
Controlled drug delivery systems
Controlled drug delivery systemsControlled drug delivery systems
Controlled drug delivery systems
 
Types of superdisintegrants
Types of superdisintegrantsTypes of superdisintegrants
Types of superdisintegrants
 
Compression coated tablet techniques by prashik
Compression coated tablet techniques by prashikCompression coated tablet techniques by prashik
Compression coated tablet techniques by prashik
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Microsphere & microcapsules
Microsphere & microcapsulesMicrosphere & microcapsules
Microsphere & microcapsules
 
Novel drug delivery system: Niosomes
Novel drug delivery system: NiosomesNovel drug delivery system: Niosomes
Novel drug delivery system: Niosomes
 
Dissolution profile comparison
Dissolution profile comparisonDissolution profile comparison
Dissolution profile comparison
 
Physics of tablet compression
Physics of tablet compressionPhysics of tablet compression
Physics of tablet compression
 
Microspheres
MicrospheresMicrospheres
Microspheres
 
NIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATIONNIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATION
 
Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]
 

En vedette

Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert Ra'Fat Ala'taby
 
Niosomes.pptx by ritu rawal
Niosomes.pptx by ritu rawalNiosomes.pptx by ritu rawal
Niosomes.pptx by ritu rawalriturawal
 
Packaging processes and equipments
Packaging processes and equipmentsPackaging processes and equipments
Packaging processes and equipmentsphysics101
 
Glass as a packaging material in pharmaceutical packaging
Glass as a packaging material in pharmaceutical packagingGlass as a packaging material in pharmaceutical packaging
Glass as a packaging material in pharmaceutical packagingShweta Shelke
 
Q.c test for packing amterial
Q.c test for packing amterialQ.c test for packing amterial
Q.c test for packing amterialkumar143vyshu4
 
Transdermal Drug Delivery System [TDDS]
Transdermal Drug Delivery System [TDDS]Transdermal Drug Delivery System [TDDS]
Transdermal Drug Delivery System [TDDS]Sagar Savale
 
Permeation enhancement through skin
Permeation enhancement through skinPermeation enhancement through skin
Permeation enhancement through skinRohit Thakur
 
Melt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulationMelt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulationSAURABH PATEL
 
fast disintegrating oral thin films
fast disintegrating oral thin filmsfast disintegrating oral thin films
fast disintegrating oral thin filmssahithi9reddy
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilsahilhusen
 
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClFORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClMohammad Adil
 
Liposomal drug delivery system
Liposomal drug delivery systemLiposomal drug delivery system
Liposomal drug delivery systemNazmul Islam
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenteralsceutics1315
 

En vedette (20)

Tdds1
Tdds1Tdds1
Tdds1
 
Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert
 
Niosomes.pptx by ritu rawal
Niosomes.pptx by ritu rawalNiosomes.pptx by ritu rawal
Niosomes.pptx by ritu rawal
 
Packaging processes and equipments
Packaging processes and equipmentsPackaging processes and equipments
Packaging processes and equipments
 
Glass as a packaging material in pharmaceutical packaging
Glass as a packaging material in pharmaceutical packagingGlass as a packaging material in pharmaceutical packaging
Glass as a packaging material in pharmaceutical packaging
 
Q.c test for packing amterial
Q.c test for packing amterialQ.c test for packing amterial
Q.c test for packing amterial
 
Transdermal Drug Delivery System [TDDS]
Transdermal Drug Delivery System [TDDS]Transdermal Drug Delivery System [TDDS]
Transdermal Drug Delivery System [TDDS]
 
Permeation enhancement through skin
Permeation enhancement through skinPermeation enhancement through skin
Permeation enhancement through skin
 
Melt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulationMelt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulation
 
fast disintegrating oral thin films
fast disintegrating oral thin filmsfast disintegrating oral thin films
fast disintegrating oral thin films
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahil
 
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClFORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
 
Liposomes
LiposomesLiposomes
Liposomes
 
Microencapsulation
Microencapsulation Microencapsulation
Microencapsulation
 
Liposomal drug delivery system
Liposomal drug delivery systemLiposomal drug delivery system
Liposomal drug delivery system
 
Liposomes
LiposomesLiposomes
Liposomes
 
Hepa filters PPT
Hepa filters PPTHepa filters PPT
Hepa filters PPT
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenterals
 
Sterile Dosage Forms
Sterile Dosage FormsSterile Dosage Forms
Sterile Dosage Forms
 
Additive substances for parenterals
Additive substances for parenteralsAdditive substances for parenterals
Additive substances for parenterals
 

Similaire à Multiparticulate drug delivery systems

Multiparticulate drugdeliverysystems
Multiparticulate drugdeliverysystemsMultiparticulate drugdeliverysystems
Multiparticulate drugdeliverysystemsDr Gajanan Sanap
 
Pelletizatoin
PelletizatoinPelletizatoin
Pelletizatoinaijazpsd
 
Why Do Glass Bottles Recyclable
Why Do Glass Bottles RecyclableWhy Do Glass Bottles Recyclable
Why Do Glass Bottles RecyclableBrittany Sevier
 
Design, Development, and Evaluation of Nsaid Drug in Soft gel Dosage Form
Design, Development, and Evaluation of Nsaid Drug in Soft gel Dosage FormDesign, Development, and Evaluation of Nsaid Drug in Soft gel Dosage Form
Design, Development, and Evaluation of Nsaid Drug in Soft gel Dosage FormBRNSSPublicationHubI
 
A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...
A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...
A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...ijtsrd
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...iosrphr_editor
 
Candesartan Case Study
Candesartan Case StudyCandesartan Case Study
Candesartan Case StudyTara Hardin
 
Oral Dispersible Tablets
Oral Dispersible TabletsOral Dispersible Tablets
Oral Dispersible TabletsSuresh Rewar
 
FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...
FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...
FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...Aditya Ceepathi
 
Mucoadhesive Drug Delivery System
Mucoadhesive Drug Delivery SystemMucoadhesive Drug Delivery System
Mucoadhesive Drug Delivery Systemijtsrd
 
formulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxformulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxPawanDhamala1
 

Similaire à Multiparticulate drug delivery systems (20)

Multiparticulate drugdeliverysystems
Multiparticulate drugdeliverysystemsMultiparticulate drugdeliverysystems
Multiparticulate drugdeliverysystems
 
Pelletization
PelletizationPelletization
Pelletization
 
Pelletizatoin
PelletizatoinPelletizatoin
Pelletizatoin
 
150720110745
150720110745150720110745
150720110745
 
Why Do Glass Bottles Recyclable
Why Do Glass Bottles RecyclableWhy Do Glass Bottles Recyclable
Why Do Glass Bottles Recyclable
 
02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf
 
02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf
 
Design, Development, and Evaluation of Nsaid Drug in Soft gel Dosage Form
Design, Development, and Evaluation of Nsaid Drug in Soft gel Dosage FormDesign, Development, and Evaluation of Nsaid Drug in Soft gel Dosage Form
Design, Development, and Evaluation of Nsaid Drug in Soft gel Dosage Form
 
Oral dipsersible film
Oral dipsersible filmOral dipsersible film
Oral dipsersible film
 
A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...
A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...
A Review on Solid Self Micro emulsifying Drug Delivery System A Method for En...
 
Film dosage form
Film dosage formFilm dosage form
Film dosage form
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
 
B0260511
B0260511B0260511
B0260511
 
Candesartan Case Study
Candesartan Case StudyCandesartan Case Study
Candesartan Case Study
 
Mouth dissolving films
Mouth dissolving filmsMouth dissolving films
Mouth dissolving films
 
Oral Dispersible Tablets
Oral Dispersible TabletsOral Dispersible Tablets
Oral Dispersible Tablets
 
FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...
FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...
FORMULATION AND IN-VITRO EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF...
 
Mucoadhesive Drug Delivery System
Mucoadhesive Drug Delivery SystemMucoadhesive Drug Delivery System
Mucoadhesive Drug Delivery System
 
1334001 anamika
1334001 anamika1334001 anamika
1334001 anamika
 
formulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxformulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptx
 

Plus de Prof. Dr. Basavaraj Nanjwade

Good laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals  and  biopharmaceuticalsGood laboratory practices for pharmaceuticals  and  biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
Packaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsPackaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsQbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsProf. Dr. Basavaraj Nanjwade
 
Development, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsDevelopment, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsProf. Dr. Basavaraj Nanjwade
 
Clinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsClinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsProf. Dr. Basavaraj Nanjwade
 

Plus de Prof. Dr. Basavaraj Nanjwade (20)

COVID-19 and Novel Drug Delivery System.ppt
COVID-19 and Novel Drug Delivery System.pptCOVID-19 and Novel Drug Delivery System.ppt
COVID-19 and Novel Drug Delivery System.ppt
 
Good laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals  and  biopharmaceuticalsGood laboratory practices for pharmaceuticals  and  biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticals
 
Opportunities and future for pharmacist
Opportunities and future for pharmacistOpportunities and future for pharmacist
Opportunities and future for pharmacist
 
Opportunities and future for pharmacist
Opportunities and future for pharmacistOpportunities and future for pharmacist
Opportunities and future for pharmacist
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery system
 
Packaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsPackaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for Pharmaceuticals
 
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsQbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
 
Opportunities and Future for Pharma Buddies
Opportunities and Future for Pharma BuddiesOpportunities and Future for Pharma Buddies
Opportunities and Future for Pharma Buddies
 
Development of Clinical Formulation
Development of Clinical FormulationDevelopment of Clinical Formulation
Development of Clinical Formulation
 
QbD for Pharma Products Development
QbD for Pharma Products DevelopmentQbD for Pharma Products Development
QbD for Pharma Products Development
 
Development, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsDevelopment, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological products
 
Clinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsClinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural products
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
 
Clinical drug development
Clinical drug developmentClinical drug development
Clinical drug development
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
 
Solid dosage forms (tablets)
Solid dosage forms (tablets)Solid dosage forms (tablets)
Solid dosage forms (tablets)
 
Solid dosage forms (capsules)
Solid dosage forms (capsules)Solid dosage forms (capsules)
Solid dosage forms (capsules)
 
Preparations in pharmacy of hospital
Preparations in pharmacy of hospitalPreparations in pharmacy of hospital
Preparations in pharmacy of hospital
 
Injectable solutions
Injectable solutionsInjectable solutions
Injectable solutions
 
Aerosols
AerosolsAerosols
Aerosols
 

Dernier

Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational PhilosophyShuvankar Madhu
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxKatherine Villaluna
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
How to Print Employee Resume in the Odoo 17
How to Print Employee Resume in the Odoo 17How to Print Employee Resume in the Odoo 17
How to Print Employee Resume in the Odoo 17Celine George
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 

Dernier (20)

Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational Philosophy
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptx
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
How to Print Employee Resume in the Odoo 17
How to Print Employee Resume in the Odoo 17How to Print Employee Resume in the Odoo 17
How to Print Employee Resume in the Odoo 17
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 

Multiparticulate drug delivery systems

  • 1. Multiparticulate Drug Delivery Systems Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Professor of Pharmaceutics KLE University College of Pharmacy, Belgaum-590 010 Karnataka, India. 1 25Feb.2011AllianceInstitute,Hyderabad
  • 2. CONTENT  Multiparticulate Drug Delivery Systems.  Pellets.  Pelletization Techniques .  Extrusion Spheronization .  Melt Extrusion.  Mini Tablets. 2 25Feb.2011AllianceInstitute,Hyderabad
  • 3. Multiparticulate Drug Delivery Systems  Pharmaceutical invention and research are increasingly focusing on delivery systems which enhance desirable therapeutic objectives while minimising side effects.  Recent trends indicate that multiparticulate drug delivery systems are especially suitable for achieving controlled or delayed release oral formulations with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric residence time. 3 25Feb.2011AllianceInstitute,Hyderabad
  • 4.  The release of drug from microparticles depends on a variety of factors including the carrier used to form the multiparticles and the amount of drug contained in them.  Consequently, multiparticulate drug delivery systems provide tremendous opportunities for designing new controlled and delayed release oral formulations, thus extending the frontier of future pharmaceutical development. 4 Multiparticulate Drug Delivery Systems 25Feb.2011AllianceInstitute,Hyderabad
  • 5. Multiparticulate Drug Delivery Systems  Multi-particulate drug delivery systems are mainly oral dosage forms consisting of a multiplicity of small discrete units, each exhibiting some desired characteristics.  In these systems, the dosage of the drug substances is divided on a plurality of subunit, typically consisting of thousands of spherical particles with diameter of 0.05- 2.00mm. 5 25Feb.2011AllianceInstitute,Hyderabad
  • 6.  Thus multiparticulate dosage forms are pharmaceutical formulations in which the active substance is present as a number of small independent subunits.  To deliver the recommended total dose, these subunits are filled into a sachet and encapsulated or compressed into a tablet. 6 Multiparticulate Drug Delivery Systems 25Feb.2011AllianceInstitute,Hyderabad
  • 7.  Multiparticulates are discrete particles that make up a multiple unit system. They provide many advantages over single-unit systems because of their small size.  Multiparticulates are less dependent on gastric empyting, resulting in less inter and intra-subject variability in gastrointestinal transit time. They are also better distributed and less likely to cause local Irritation. Multiparticulate Drug Delivery Systems 7 25Feb.2011AllianceInstitute,Hyderabad
  • 8.  Recently much emphasis is being laid on the development of multiparticulate dosage forms in preference to single unit systems because of their potential benefits such as increased bioavailability, reduced risk of systemic toxicity, reduced risk of local irritation and predictable gastric emptying. Multiparticulate Drug Delivery Systems 8 25Feb.2011AllianceInstitute,Hyderabad
  • 9. Multiparticulate Drug Delivery Systems  There are many reasons for formulating a drug as a multiparticulate system for example, to facilitate disintegration in the stomach, or to provide a convenient, fast disintegrating tablet that dissolves in water before swallowing which can aid compliance in older patients and children.  Multiparticulate systems show better reproducible pharmacokinetic behavior than conventional (monolithic) formulations. 9 25Feb.2011AllianceInstitute,Hyderabad
  • 10.  After disintegration which occurs within a few minutes often even within seconds, the individual subunit particles pass rapidly through the GI tract.  If these subunits have diameters of less than 2mm, they are able to leave the stomach continuously, even if the pylorus is closed.  These results in lower intra and inter individual variability in plasma levels and bioavailability. 10 Multiparticulate Drug Delivery Systems 25Feb.2011AllianceInstitute,Hyderabad
  • 11. MECHANISM OF DRUG RELEASE FROM MULTI- PARTICULATES  The mechanism of drug release from multiparticulates can be occur in the following ways:-  Diffusion  Erosion  Osmosis 11 25Feb.2011AllianceInstitute,Hyderabad
  • 12. MECHANISM OF DRUG RELEASE FROM MULTI- PARTICULATES  Diffusion :- On contact with aqueous fluids in the gastrointestinal tract (GIT), water diffuses into the interior of the particle. Drug dissolution occurs and the drug solutions diffuse across the release coat to the exterior.  Erosion :- Some coatings can be designed to erode gradually with time, thereby releasing the drug contained within the particle.  Osmosis :- In allowing water to enter under the right circumstances, an osmotic pressure can be built up within the interior of the particle. The drug is forced out of the particle into the exterior through the coating. 12 25Feb.2011AllianceInstitute,Hyderabad
  • 13. PELLETS o WHAT IS PELLETS:- o Traditionally, the word "pellet" has been used to describe the variety of systematically produced, geometrically defined agglomerates obtained from diverse starting materials utilizing different processing conditions. o These products may be fertilizers, Animal feeds, Iron Ores or Pharmaceutical Dosage forms. o Pellets are small spherical free flowing units with improved flow properties and flexibility in formulation development and manufacture. 13 25Feb.2011AllianceInstitute,Hyderabad
  • 14. PELLETS  Their size and shape allow their administration as injections and also for oral drug delivery.  Pellets range in size, typically, between 0.5 – 1.5 mm, though other sizes could be prepared.  Pellets are for pharmaceutical purposes and are produced primarily for the purpose of oral controlled-release dosage forms having gastro resistant or sustained-release properties or the capability of site-specific drug delivery. 14 25Feb.2011AllianceInstitute,Hyderabad
  • 15. PELLETS  For such purposes, coated pellets are administered in the form of hard gelatin capsules or disintegrating tablets that quickly liberate their contents of pellets in the stomach.  As drug-delivery systems become more sophisticated, the role of pellets in the design and development of dosage forms is increasing.  Formulation of drugs in multiple-unit dosage forms, such as coated pellets filled in capsules or compressed into tablets, offers flexibility as to target-release properties. 15 25Feb.2011AllianceInstitute,Hyderabad
  • 16. WHY PELLETS?  Excellent Stability.  Dust free Round pellets.  Good flow behavior.  Easy to dose.  Compact structure.  Very Low hygroscopicity.  High bulk density.  Dense, uniform surface. PELLETIZATION 16 25Feb.2011AllianceInstitute,Hyderabad
  • 17.  Narrow grain size distribution.  Low abrasion.  High active ingredient content possible.  Optimum starting shape for subsequent coating.  Controlled-release applications.  Drug absorption.  The risks of the local damage to the GI- tract mucosal. WHY PELLETS? 17 25Feb.2011AllianceInstitute,Hyderabad
  • 18. ADVANTAGES OF PELLETS  They can be divided in to desired dosage strength without process or formulation changes.  When pellets containing the active ingredient are in the form of suspension, capsules, or disintegrating tablets, they offer significant therapeutic advantages over single unit dosage forms.  They can also be blended to deliver incompatible bioactive agents.  They can also be used to provide different release profile at the same or different sites in the gastrointestinal tract. 18 25Feb.2011AllianceInstitute,Hyderabad
  • 19. ADVANTAGES OF PELLETS  Pellets offer high degree of flexibility in the design and development of oral dosage form like suspension, sachet, tablet and capsule.  Pellets disperse freely in GI tract, maximize drug absorption, and minimize local irritation of the mucosa by certain irritant drugs.  Improved flow characteristics: Spheres have excellent flow properties which can be used in automated processes or in processes where exact dosing is required, e.g. tabletting, moulding operations, capsule filling, and packaging. 19 25Feb.2011AllianceInstitute,Hyderabad
  • 20. Disadvantages of Pellets  Dosing by volume rather than number and splitting into single dose units as required.  Involves capsule filling which can increase the costs or tabletting which destroy film coatings on the pellets.  The size of pellets varies from formulation to formulation but usually lies between 1 to 2mm. 20 25Feb.2011AllianceInstitute,Hyderabad
  • 21. PELLETIZATION DEFINITION OF PELLETIZATION  Pelletization is an agglomeration process, that converts fine powder blend of drug(s) and Excipients into small, free flowing, spherical units, referred to as pellets. 21 25Feb.2011AllianceInstitute,Hyderabad
  • 22. PELLETIZATION  Pelletization is referred to as a size enlargement process and if the final agglomerates are spherical with a size of 0.5-2.0 mm and low intra-agglomerate porosity (about 10%), they are called pellets. 22 25Feb.2011AllianceInstitute,Hyderabad
  • 23. PELLETIZATION TECHNIQUES  Powder layering Solution/Suspension layering.  Extrusion–Spheronization.  Spherical agglomeration or balling Spray congealing/ drying.  Cryopelletization and,  Melt Spheronization. 23 25Feb.2011AllianceInstitute,Hyderabad
  • 24. PELLETIZATION TECHNIQUES POWDER LAYERING  Powder layering involves the deposition of successive layers of dry powder of drug or excipients or both on preformed nuclei or cores with the help of a binding liquid.  Powder layering involves the simultaneous application of the binding liquid and dry powder. 24 25Feb.2011AllianceInstitute,Hyderabad
  • 25. POWDER LAYERING  The first equipment used to manufacture pellets on a commercial scale was the conventional coating pan, but it has significant limitations as pelletization equipment.  The degree of mixing is very poor, and the drying process is not efficient 25 PELLETIZATION TECHNIQUES 25Feb.2011AllianceInstitute,Hyderabad
  • 26. POWDER LAYERING Principle of Powder layering process 26 25Feb.2011AllianceInstitute,Hyderabad
  • 27. POWDER LAYERING  Throughout the process, it is extremely important to deliver the powder accurately at a predetermined rate and in a manner that maintains equilibrium between the binder liquid application rate and the powder delivery rate.  If the powder delivery rate is not maintained at predetermined equilibrium levels, over wetting or dust generation may occur, and neither the quality nor the yield of the product can be maximized.  In an ideal process, no agglomeration occurs, and the particle population at the end of the process remains the same as that of the starter seeds or cores, with the only difference being an increase in the size of the pellets 27 25Feb.2011AllianceInstitute,Hyderabad
  • 28. Solution/Suspension layering  Solution/suspension layering involves the deposition of successive layers of solutions and/or suspensions of drug substances and binders on starter seeds, which may be inert materials or crystals/granules of the same drug.  A starting grain or a pellet can be presented as the starting material. The pellet is built up to the required grain size by adding the layering substance one layer at a time. Powder and binders, suspensions or solutions make suitable layering substances. 28 25Feb.2011AllianceInstitute,Hyderabad
  • 29. Solution/Suspension layering  Thick layers can be applied to the starting grains, which, in the case of layers containing active ingredients, allow large amounts of active ingredient to be incorporated. 29 25Feb.2011AllianceInstitute,Hyderabad
  • 30. Solution/Suspension layering  An important factor that needs to be considered when suspensions are used as opposed to solutions is the particle size of the drug.  Micronized drug particles tend to provide pellets that are smooth in appearance, a property that is extremely desirable during subsequent film coating, particularly for controlled-release applications. 30 25Feb.2011AllianceInstitute,Hyderabad
  • 31. Solution/Suspension layering  If the particle size of the drug in the suspension is large, the amount of binder required to immobilize the particles onto the cores will be high, and, consequently, pellets of low potency are produced.  The morphology of the finished pellets also tends to be rough and may adversely affect the coating process and the coated product. 31 25Feb.2011AllianceInstitute,Hyderabad
  • 32. Extrusion Spheronization  Compared to single-unit dosage forms, oral multiparticulate drug-delivery systems (e.g. pellets, granules) offer biopharmaceutical advantages in terms of a more even and predictable distribution and transportation in the gastro-intestinal tract.  There are different pelletizations and granulation techniques available to prepare drug loaded spherical particles or granules.  Extrusion Spheronization is one of them and utilized in formulation of beads and pellets. 32 25Feb.2011AllianceInstitute,Hyderabad
  • 33. Extrusion Spheronization  Limitations related to bioavailability and site specific drug delivery can be over come by this technique.  Today this technology has gained attention because of its simple and fast processing.  Extrusion spheronization is widely utilized in formulation of sustained release, controlled release delivery system.  The main objective of the extrusion spheronization is to produce pellets/spheroids of uniform size with high drug loading capacity. 33 25Feb.2011AllianceInstitute,Hyderabad
  • 34. Extrusion Spheronization  The extrusion-spheronization process is commonly used in the pharmaceutical industry to make uniformly sized spheroids.  It is especially useful for making dense granules for controlled-release solid dosage oral forms with a minimum amount of excipients.  Extrusion/spheronization begins with extrusion process in which the wet metered mass is placed into the extruder where it is continuously formed into cylindrical rods of uniform size and shape. 34 25Feb.2011AllianceInstitute,Hyderabad
  • 35. Extrusion Spheronization  Amount of granulating fluid and uniform dispersion of fluid plays an important role in preparation of wet mass as optimum plasticity and cohesiveness directly affect the final production of pellets.  Once the extrudates are prepared, they are then taken to spheroniser where it is spheronized or rotated at higher speed by friction plate that breaks the rod shaped particles into smaller particles and round them to form spheres. 35 25Feb.2011AllianceInstitute,Hyderabad
  • 36. Extrusion Spheronization  The size of the spheroids mainly depends on the diameter of circular die that modifies the diameter of cylindrical rods produced in extrusion stage. 36 25Feb.2011AllianceInstitute,Hyderabad
  • 37. Extrusion Spheronization  The extrusion-spheronization process can be broken down into the following steps: 1.  Dry mixing of the active ingredients and excipients to achieve a homogenious powder. 2. Wet massing, with binder added to the dry mixture 3. Extrusion into a spaghetti-like extrudate. 4. Spheronization to from the extrudate in to spheroids of uniform size. 5. Drying. 6. Dry sizing, or sifting (optional) to achieve the desired size distribution 7. Coating (optional). 37 25Feb.2011AllianceInstitute,Hyderabad
  • 38. Extrusion Spheronization  The extrusion-spheronization process can be broken down. 38 25Feb.2011AllianceInstitute,Hyderabad
  • 39. Extrusion Spheronization  Product features • Dust free • High spherocity • Free flowing • Compact structure • Low hygroscopicity • High bulk density • Low abrasion • Narrow particle size distribution • Smooth surface 39 25Feb.2011AllianceInstitute,Hyderabad
  • 40. MELT EXTRUSION  Melt extrusion is one of the most widely applied processing technologies in the plastic, rubber and food industry. Today this technology has found its place in the array of pharmaceutical manufacturing operations.  Melt extrusion process are currently applied in the pharmaceutical field for the manufacture of a variety of dosage forms and formulations such as granules, pellets, tablets, suppositories, implants, stents, transdermal systems and ophthalmic inserts. 40 25Feb.2011AllianceInstitute,Hyderabad
  • 41. MELT EXTRUSION Advantages:  Neither solvent nor water used in this process.  Fewer processing steps needed thus time consuming drying steps eliminated.  There are no requirements on the compressibility of active ingredients and the entire procedure simple, continuous and efficient. 41 25Feb.2011AllianceInstitute,Hyderabad
  • 42. MELT EXTRUSION Advantages:  Uniform dispersion of fine particle occurs.    Good stability at varying pH and moisture levels.    Safe application in humans due to their non-swellable and water insoluble nature 42 25Feb.2011AllianceInstitute,Hyderabad
  • 43. MELT EXTRUSION Disadvantages:   Requires high energy input.    The melt technique is that the process cannot be applied to heat-sensitive materials owing to the elevated temperatures involved.    Lower-melting-point binder risks situations where melting or softening of the binder occurs during handling and storage of the agglomerates 43 25Feb.2011AllianceInstitute,Hyderabad
  • 44. MELT EXTRUSION Applications in the pharmaceutical industry:  In pharmaceutical industry the melt extrusion has been used for various purposes, such as  1. Improving the dissolution rate and bioavailability of the drug by forming a solid  dispersion or solid solution.    2. Controlling or modifying the release of the drug.  3.    Masking the bitter taste of an active drug 44 25Feb.2011AllianceInstitute,Hyderabad
  • 45. MELT EXTRUSION  Melt extrusion technology has proven to be a suitable method for the production of controlled release reservoir systems consisting of polyethylene vinyl acetate (PVA) co-polymers.  Based on this technology, two controlled release systems Implanon® and Nuvaring® have been developed.  A melt extrusion process for manufacturing matrix drug delivery system was reported by Sprockel and co- workers. In 1994 Follonier and co-workers investigated hot-melt extrusion technology to produce sustained- release pellets. 45 25Feb.2011AllianceInstitute,Hyderabad
  • 46. MELT EXTRUSION Process and Equipment:  Hot-melt extrusion equipment consists of an extruder, auxiliary equipment for the extruder, down stream processing equipment, and other monitoring tools used for performance and product quality evaluation.  The extruder is typically composed of a feeding hopper, barrels, single or twin screws, and the die and screw– driving unit 46 25Feb.2011AllianceInstitute,Hyderabad
  • 47. MELT EXTRUSION Figure: Micro-18 Twin screw co-rotating Leistritz extruder 47 25Feb.2011AllianceInstitute,Hyderabad
  • 48. MELT EXTRUSION  The auxiliary equipment for the extruder mainly consists of a heating/cooling device for the barrels, a conveyer belt to cool down the product and a solvent delivery pump.  The monitoring devices on the equipment include temperature gauges, a screw-speed controller, an extrusion torque monitor and pressure gauges.  The monitoring devices on the equipment include temperature gauges, a screw-speed controller, an extrusion torque monitor and pressure gauges. 48 25Feb.2011AllianceInstitute,Hyderabad
  • 49. MELT EXTRUSION  The theoretical approach to understanding the melt extrusion process is therefore, generally presented by dividing the process of flow into four sections: 1) Feeding of the extruder. 2) Conveying of mass (mixing and reduction of particle size). 3) Flow through the die. 4) Exit from the die and down-stream processing. 49 25Feb.2011AllianceInstitute,Hyderabad
  • 50. MELT EXTRUSION Figure 2. Heating barrels and co-rotating screws for hot-melt extruder 50 25Feb.2011AllianceInstitute,Hyderabad
  • 51. MINI TABLETS  It is well known that solid oral dosage form, particularly tablets, are the most acceptable form of delivering medication.  However, some new variations are beginning to emerge such as mini-tabs, which offer formulation flexibility. 51 25Feb.2011AllianceInstitute,Hyderabad
  • 52.  Mini-tabs are small tablets with a diameter typically equal to or less than 3 mm that are typically filled into a capsule, or occasionally, further compressed into larger tablets.  It is possible to incorporate many different mini-tablets, each one formulated individually and programmed to release drug at different sites within the gastrointestinal track, into one capsule. 52 MINI TABLETS 25Feb.2011AllianceInstitute,Hyderabad
  • 54. MINI TABLETS Fig. Mini-tablets delivered as a tablet (a) or a capsule (b). 54 25Feb.2011AllianceInstitute,Hyderabad
  • 55. MINI TABLETS  These combinations may include immediate release, delayed release, and/or controlled release mini-tabs.  It is also possible to incorporate mini-tabs of different drugs to treat concurrent diseases or combinations of drugs to improve overall therapeutic outcome, while delivering distinct release rates of each according to disease requirements.  Mini-tabs could also offer a solution to the current issue in the pharmaceutical industry representing a lack of dosage forms which are suitable for pediatrics. 55 25Feb.2011AllianceInstitute,Hyderabad
  • 56. MINI TABLETS  Additional benefits of mini-tabs include excellent size uniformity, regular shape and a smooth surface, thereby offering an excellent substrate for coating with modified release polymeric systems.  They can be produced via direct compression and can be manufactured using conventional tableting machines with only minor equipment modifications.  For example, in order to increase production speeds, multiple-tip tooling has been employed routinely. Furthermore, mini-tabs can be coated using either a perforated coating pan or a fluid bed apparatus. 56 25Feb.2011AllianceInstitute,Hyderabad